Call launched: 15th June 2022
Deadline: 19th October 2022
Who is eligible: Individual applicants or small consortia (two partners).
Topic relevant for FM MU: CARDIOGENOMICS
The aim is to identify single or multiple gene variants of high biological significance or other key molecules associated with the CVDs that would allow for accurate stratification of patients and guide the physician in their clinical management and monitoring of these CVDs; to identify novel targets based on these variants for specific CVD indication(s) that would allow for the development of first in class therapies for the same indication; to seek for novel technological solutions that could contribute to the development and acceleration of first in class therapies for major CVD conditions for which no effective treatments are currently available.
Specific conditions: Applicants must convincingly demonstrate that they have access to a large cohort of genomic and/or transcriptomics and/or proteomics and/or metabolomics database from CVD patients.
More information can be found in EIC Work Programme 2022.
Please contact us for more information.